Appendix 4E 1. Company details Name of entity: Genetic Signatures Limited ABN: 30 095 913 205 Reporting period: For the year ended 30 June 2026 Previous period: For the year ended 30 June 2025 2. Results for announcement to the market $'000 Revenues from...
FY26 Appendix 4E and Annual Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Genetic Signatures Ltd. on 6ix
Story so far
Earlier from Genetic Signatures
- FY 26 Annual Results and Investor Webinar Notification
- Commercial Testing Commences at Hvidovre Hospital in Denmark
- GSS responds to the BCAL Diagnostics Announcement
- BCAL to Acquire Shares in Genetic Signatures
- Danish Supply Agreement - Additional Information
Later from Genetic Signatures
- FY26 Results Release
- FY26 Appendix 4G and Corporate Governance Statement
- FY26 Market Update
- Change in substantial holding
- Change in Substantial Shareholder Notice for GSS
Follow Genetic Signatures into a list and get an email when it puts out news.
Follow Genetic Signatures
